Intermittent Hypoxia-Induced Carotid Body Chemosensory Potentiation and Hypertension Are Critically Dependent on Peroxynitrite Formation

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Moya, Esteban A ^a   Arias, Paulina ^c   Varela, Carlos ^a   Oyarce, María P ^a   Del Rio, Rodrigo ^b   Iturriaga, Rodrigo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^c UNIVERSIDAD CIENTÍFICA DEL SUR   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; SLEEP RESEARCH;

ARTERIAL BLOOD PRESSURE; CHEMOSENSITIVITY; CHRONIC INTERMITTENT HYPOXIAS; IMMUNOREACTIVITIES; INTERMITTENT HYPOXIAS; OBSTRUCTIVE SLEEP APNEA; REACTIVE NITROGEN SPECIES; SPRAGUE-DAWLEY RATS;

RATS;

3 NITROTYROSINE; EBSELEN; PEROXYNITRITE; 3-NITROTYROSINE; ORGANOSELENIUM DERIVATIVE; PEROXYNITROUS ACID; PYRROLE DERIVATIVE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CAROTID BODY CHEMORECEPTOR; CHEMOSENSITIVITY; CHRONIC INTERMITTENT HYPOXIA; CONTROLLED STUDY; HYPERTENSION; IMMUNOREACTIVITY; MALE; MEAN ARTERIAL PRESSURE; NITRATION; NONHUMAN; OSMOTIC MINIPUMP; PULSE PRESSURE; RAT; RESTING HEART RATE; TELEMETRY; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; CAROTID BODY; COMPLICATION; DIASTOLE; DRUG EFFECTS; HYPOXIA; METABOLISM; NERVE CELL PLASTICITY; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; SYSTOLE;

ANIMALS; AZOLES; BLOOD PRESSURE; CAROTID BODY; DIASTOLE; HYPERTENSION; HYPOXIA; MALE; NEURONAL PLASTICITY; ORGANOSELENIUM COMPOUNDS; PEROXYNITROUS ACID; RATS, SPRAGUE-DAWLEY; SYSTOLE; TYROSINE;

EID: 84954286574     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/9802136     Document Type: Article

References (45)

1. V. K. Somers, D. P. White, R. Amin et al., "Sleep apnea and cardiovascular disease an American Heart Association/American College of cardiology foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health), " Circulation, vol. 118, no. 10, pp. 1080-1110, 2008.
2. J. A. Dempsey, S. C. Veasey, B. J. Morgan, and C. P.ODonnell, "Pathophysiology of sleep apnea, " Physiological Reviews, vol. 90, no. 1, pp. 47-112, 2010.
3. D. Gozal and L. Kheirandish-Gozal, "Cardiovascular morbidity in obstructive sleep apnea, " American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 4, pp. 369-375, 2008.
4. T. Young, M. Palta, J. Dempsey, J. Skatrud, S. Weber, and S. Badr, "The occurrence of sleep-disordered breathing among middleaged adults, "The New England Journal ofMedicine, vol. 328, no. 17, pp. 1230-1235, 1993.
5. L. Lavie, "Obstructive sleep apnoea syndrome-An oxidative stress disorder, " Sleep Medicine Reviews, vol. 7, no. 1, pp. 35-51, 2003.
6. J. F. Garvey, C.T. Taylor, and W.T. McNicholas, "Cardiovascular disease in obstructive sleep apnoea syndrome: The role of intermittent hypoxia and inflammation, " European Respiratory Journal, vol. 33, no. 5, pp. 1195-1205, 2009.
7. R. Iturriaga, E. A. Moya, and R. Del Rio, "Carotid body potentiation induced by intermittent hypoxia: implications for cardiorespiratory changes induced by sleep apnoea, " Clinical and Experimental Pharmacology and Physiology, vol. 36, no. 12, pp. 1197-1204, 2009.
8. Y.-J. Peng, J. L. Overholt, D. Kline, G. K. Kumar, and N. R. Prabhakar, "Induction of sensory long-Term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 17, pp. 10073-10078, 2003.
9. R. Del Rio, E. A. Moya, and R. Iturriaga, "Carotid body and cardiorespiratory alterations in intermittent hypoxia: The oxidative link, " European Respiratory Journal, vol. 36, no. 1, pp. 143-150, 2010.
10. R. Del Rio, E. A. Moya, M. J. Parga, C. Madrid, and R. Iturriaga, "Carotid body inflammation and cardiorespiratory alterations in intermittent hypoxia, " European Respiratory Journal, vol. 39, no. 6, pp. 1492-1500, 2012.
11. Y.-J. Peng and N. R. Prabhakar, "Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity, " Journal of Applied Physiology, vol. 96, no. 3, pp. 1236-1242, 2004.
12. S. Rey, R. Del Rio, J. Alcayaga, and R. Iturriaga, "Chronic intermittent hypoxia enhances cat chemosensory and ventilatory responses to hypoxia, " The Journal of Physiology, vol. 560, no. 2, pp. 577-586, 2004.
13. K. Narkiewicz, P. J. H. van de Borne, C. A. Pesek, M. E. Dyken, N. Montano, and V. K. Somers, "Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea, " Circulation, vol. 99, no. 9, pp. 1183-1189, 1999.
14. S. Rey, M. P. Tarvainen, P. A. Karjalainen, and R. Iturriaga, "Dynamic time-varying analysis of heart rate and blood pressure variability in cats exposed to short-Term chronic intermittent hypoxia, " American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol. 295, no. 1, pp. R28-R37, 2008.
15. R. Iturriaga, D. C. Andrade, and R. Del Rio, "Enhanced carotid body chemosensory activity and the cardiovascular alterations induced by intermittent hypoxia, " Frontiers in Physiology, vol. 5, article 468, 2015.
16. R. Iturriaga, E. A. Moya, and R. Del Rio, "Inflammation and oxidative stress during intermittent hypoxia: The impact on chemoreception, " Experimental Physiology, vol. 100, no. 2, pp. 149-155, 2015.
17. C. Gonzalez, G. Sanz-Alyayate, M. T. Agapito, and A. Obeso, "Effects of reducing agents on glutathione metabolism and the function of carotid body chemoreceptor cells, " Biological Chemistry, vol. 385, no. 3-4, pp. 265-274, 2004.
18. R. Del Rio, E.A. Moya, and R. Iturriaga, "Differential expression of pro-inflammatory cytokines, endothelin-1 and nitric oxide synthases in the rat carotid body exposed to intermittent hypoxia, " Brain Research, vol. 1395, pp. 74-85, 2011.
19. A. Daiber, M.-H. Zou, M. Bachschmid, and V. Ullrich, "Ebselen as a peroxynitrite scavenger in vitro and ex vivo, " Biochemical Pharmacology, vol. 59, no. 2, pp. 153-160, 2000.
20. Y. Nakamura, Q. Feng, T. Kumagai et al., "Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant. Implication for inflammation-Associated carcinogenesis, "The Journal of Biological Chemistry, vol. 277, no. 4, pp. 2687-2694, 2002.
21. G. K. Azad and R. S. Tomar, "Ebselen, a promising antioxidant drug:mechanisms of action and targets of biological pathways, " Molecular Biology Reports, vol. 41, no. 8, pp. 4865-4879, 2014.
22. J.-G. Park, J.-Y. Yoo, S.-J. Jeong et al., "Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice, " Circulation Research, vol. 109, no. 7, pp. 739-749, 2011.
23. A.H. Bubolz, Q. Wu, B. T. Larsen, D. D. Gutterman, andY. Liu, "Ebselen reduces nitration and restores voltage-gated potassium channel function in small coronary arteries of diabetic rats, " American Journal of Physiology: Heart and Circulatory Physiology, vol. 293, no. 4, pp. H2231-H2237, 2007.
24. C. M. Troncoso Brindeiro, A. Q. da Silva, K. J. Allahdadi, V. Youngblood, and N. L. Kanagy, "Reactive oxygen species contribute to sleep apnea-induced hypertension in rats, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 293, no. 5, pp. H2971-H2976, 2007.
25. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, "Free radicals and antioxidants in normal physiological functions and human disease, " International Journal of Biochemistry and Cell Biology, vol. 39, no. 1, pp. 44-84, 2007.
26. R. A. Dweik, "Nitric oxide, hypoxia, and superoxide: The good, the bad, and the ugly!, " Thorax, vol. 60, no. 4, pp. 265-267, 2005.
27. G. Ferrer-Sueta and R. Radi, "Chemical biology of peroxynitrite: kinetics, diffusion, and radicals, " ACS Chemical Biology, vol. 4, no. 3, pp. 161-177, 2009.
28. A. G. Estevez and J. Jordan, "Nitric oxide and superoxide, a deadly cocktail, " Annals of the New York Academy of Sciences, vol. 962, pp. 207-211, 2002.
29. J. S. Beckman and W. H. Koppenol, "Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly, " The American Journal of Physiology-Cell Physiology, vol. 271, no. 5, pp. C1424-C1437, 1996.
30. E. A. Moya, J. Alcayaga, and R. Iturriaga, "NO modulation of carotid body chemoreception in health and disease, " Respiratory Physiology & Neurobiology, vol. 184, no. 2, pp. 158-164, 2012.
31. R. Iturriaga, M. Mosqueira, and S. Villanueva, "Effects of nitric oxide gas on cat carotid body chemosensory response to hypoxia, " Brain Research, vol. 855, no. 2, pp. 282-286, 2000.
32. N. J. Marcus, Y.-L. Li, C. E. Bird, H.D. Schultz, and B. J. Morgan, "Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor, " Respiratory Physiology and Neurobiology, vol. 171, no. 1, pp. 36-45, 2010.
33. P. Pacher, J. S. Beckman, and L. Liaudet, "Nitric oxide and peroxynitrite in health and disease, " Physiological Reviews, vol. 87, no. 1, pp. 315-424, 2007.
34. C. Szabo, H. Ischiropoulos, and R. Radi, "Peroxynitrite: biochemistry, pathophysiology and development of therapeutics, " Nature Reviews Drug Discovery, vol. 6, no. 8, pp. 662-680, 2007.
35. F. Yamakura and H. Kawasaki, "Post-Translational modifications of superoxide dismutase, " Biochimica et Biophysica Acta, vol. 1804, no. 2, pp. 318-325, 2010.
36. J. T. Hancock, R. Desikan, and S. J. Neill, "Role of reactive oxygen species in cell signalling pathways, " Biochemical Society Transactions, vol. 29, no. 2, pp. 345-349, 2001.
37. J. J. Haddad, "Oxygen sensing and oxidant/redox-related pathways, " Biochemical and Biophysical Research Communications, vol. 316, no. 4, pp. 969-977, 2004.
38. L. A. MacMillan-Crow, D. L. Cruthirds, K. M. Ahki, P. W. Sanders, and J. A. Thompson, "Mitochondrial tyrosine nitration precedes chronic allograft nephropathy, " Free Radical Biology and Medicine, vol. 31, no. 12, pp. 1603-1608, 2001.
39. M. A. Abdelmegeed and B.-J. Song, "Functional roles of protein nitration in acute and chronic liver diseases, " Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 149627, 21 pages, 2014.
40. A. Martinez, M. Portero-Otin, R. Pamplona, and I. Ferrer, "Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates, " Brain Pathology, vol. 20, no. 2, pp. 281-297, 2010.
41. J. P. Casanova, M. Contreras, E. A. Moya, F. Torrealba, and R. Iturriaga, "Effect of insular cortex inactivation on autonomic and behavioral responses to acute hypoxia in conscious rats, " Behavioural Brain Research, vol. 253, pp. 60-67, 2013.
42. N. Singh, A. C. Halliday, J. M. Thomas et al., "A safe lithium mimetic for bipolar disorder, " Nature Communications, vol. 4, article 1332, 2013.
43. E. C. Fletcher, G. Bao, and R. Li, "Renin activity and blood pressure in response to chronic episodic hypoxia, " Hypertension, vol. 34, no. 2, pp. 309-314, 1999.
44. N. J. Marcus, N. R. Philippi, C. E. Bird, Y.-L. Li, H. D. Schultz, and B. J. Morgan, "Effect of AT 1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction, " Respiratory Physiology and Neurobiology, vol. 183, no. 2, pp. 67-74, 2012.
45. W. D. Knight, A. Saxena, B. Shell, T. P. Nedungadi, S.W. Mifflin, and J. T. Cunningham, "Central losartan attenuates increases in arterial pressure and expression of FosB/FosB along the autonomic axis associated with chronic intermittent hypoxia, " American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 305, no. 9, pp. R1051-R1058, 2013.